Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-10-20 to 2022-11-10
Current total value of award: $21289.8
Description: 4558865973!TYSABRI 300 MG/15 ML VIAL 15ML